| scholarly article | Q13442814 |
| P50 | author | Tai-Hwan Ha | Q51090774 |
| Joon Sig Choi | Q59450892 | ||
| P2093 | author name string | Su Jeong Song | |
| Seulgi Lee | |||
| Jeil Lee | |||
| P2860 | cites work | Clinical pharmacokinetics of docetaxel. | Q30657347 |
| Cisplatin in cancer therapy: molecular mechanisms of action | Q34098163 | ||
| Doxorubicin pathways: pharmacodynamics and adverse effects | Q35048393 | ||
| Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery | Q35809872 | ||
| Surface engineering of liposomes for stealth behavior | Q37415968 | ||
| Liposomal paclitaxel formulations | Q38044520 | ||
| Cathepsin B as a cancer target | Q38072054 | ||
| Thermosensitive liposomes for localized delivery and triggered release of chemotherapy | Q38098811 | ||
| Application of liposomes in medicine and drug delivery | Q38249220 | ||
| New Developments in Liposomal Drug Delivery | Q38502540 | ||
| Challenges in carrier-mediated intracellular delivery: moving beyond endosomal barriers. | Q38626721 | ||
| Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery. | Q38860779 | ||
| High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway. | Q40127716 | ||
| Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing | Q42173308 | ||
| Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy | Q46479657 | ||
| Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | Q46515132 | ||
| Cancer nanomedicine: a review of recent success in drug delivery | Q47102124 | ||
| NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel | Q47614146 | ||
| Amphiphilic Peptide Nanorods Based on Oligo-Phenylalanine as a Biocompatible Drug Carrier. | Q47957550 | ||
| A photosensitive liposome with NIR light triggered doxorubicin release as a combined photodynamic-chemo therapy system | Q50167036 | ||
| Clinical cancer nanomedicine | Q65556503 | ||
| Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties | Q73831975 | ||
| Controlled drug delivery vehicles for cancer treatment and their performance | Q88114831 | ||
| Mitochondria Targeting Non-Isocyanate-Based Polyurethane Nanocapsules for Enzyme-Triggered Drug Release | Q90412548 | ||
| Smart cancer nanomedicine | Q91152077 | ||
| Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile | Q92081825 | ||
| Polyamidoamine (PAMAM) Dendrimers Modified with Cathepsin-B Cleavable Oligopeptides for Enhanced Gene Delivery | Q93007155 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P577 | publication date | 2020-09-14 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells | |
| P478 | volume | 12 |
Search more.